ACH PE Ratio & Valuation,Is ACH Overvalued

ACH Relative Valuation

ACH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ACH is overvalued; if below, it's undervalued.

Historical Valuation

Accendra Health Inc (ACH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 2.78 is considered Undervalued compared with the five-year average of 3.31. The fair price of Accendra Health Inc (ACH) is between 2.86 to 3.18 according to relative valuation methord. Compared to the current price of 2.36 USD , Accendra Health Inc is Undervalued By 17.58%.

Relative Value

Fair Zone

2.86-3.18

Current Price：2.36

17.58%

Undervalued

2.78

6.61

EV/EBITDA

Accendra Health Inc. (ACH) has a current EV/EBITDA of 6.61. The 5-year average EV/EBITDA is 6.70. The thresholds are as follows: Strongly Undervalued below 6.62, Undervalued between 6.62 and 6.66, Fairly Valued between 6.74 and 6.66, Overvalued between 6.74 and 6.78, and Strongly Overvalued above 6.78. The current Forward EV/EBITDA of 6.61 falls within the Strongly Undervalued range.

11.20

EV/EBIT

Accendra Health Inc. (ACH) has a current EV/EBIT of 11.20. The 5-year average EV/EBIT is 11.36. The thresholds are as follows: Strongly Undervalued below 11.22, Undervalued between 11.22 and 11.29, Fairly Valued between 11.43 and 11.29, Overvalued between 11.43 and 11.50, and Strongly Overvalued above 11.50. The current Forward EV/EBIT of 11.20 falls within the Strongly Undervalued range.

0.07

Accendra Health Inc. (ACH) has a current PS of 0.07. The 5-year average PS is 0.08. The thresholds are as follows: Strongly Undervalued below 0.07, Undervalued between 0.07 and 0.07, Fairly Valued between 0.09 and 0.07, Overvalued between 0.09 and 0.09, and Strongly Overvalued above 0.09. The current Forward PS of 0.07 falls within the Strongly Undervalued range.

0.60

P/OCF

Accendra Health Inc. (ACH) has a current P/OCF of 0.60. The 5-year average P/OCF is 0.71. The thresholds are as follows: Strongly Undervalued below 0.61, Undervalued between 0.61 and 0.66, Fairly Valued between 0.76 and 0.66, Overvalued between 0.76 and 0.81, and Strongly Overvalued above 0.81. The current Forward P/OCF of 0.60 falls within the Strongly Undervalued range.

1.21

P/FCF

Accendra Health Inc. (ACH) has a current P/FCF of 1.21. The 5-year average P/FCF is 1.43. The thresholds are as follows: Strongly Undervalued below 1.23, Undervalued between 1.23 and 1.33, Fairly Valued between 1.53 and 1.33, Overvalued between 1.53 and 1.63, and Strongly Overvalued above 1.63. The current Forward P/FCF of 1.21 falls within the Strongly Undervalued range.

Accendra Health Inc (ACH) has a current Price-to-Book (P/B) ratio of -0.42. Compared to its 3-year average P/B ratio of -0.50 , the current P/B ratio is approximately -15.84% higher. Relative to its 5-year average P/B ratio of -0.50, the current P/B ratio is about -15.84% higher. Accendra Health Inc (ACH) has a Forward Free Cash Flow (FCF) yield of approximately -189.39%. Compared to its 3-year average FCF yield of -160.17%, the current FCF yield is approximately 18.24% lower. Relative to its 5-year average FCF yield of -160.17% , the current FCF yield is about 18.24% lower.

-0.42

P/B

Median3y

-0.50

Median5y

-0.50

-189.39

FCF Yield

Median3y

-160.17

Median5y

-160.17

Competitors Valuation Multiple

The average P/S ratio for ACH's competitors is 88.01, providing a benchmark for relative valuation. Accendra Health Inc Corp (ACH) exhibits a P/S ratio of 0.07, which is -99.92% above the industry average. Given its robust revenue growth of 1.52%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of ACH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of ACH in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is Accendra Health Inc (ACH) currently overvalued or undervalued?

What is Accendra Health Inc (ACH) fair value?

ACH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Accendra Health Inc (ACH) is between 2.86 to 3.18 according to relative valuation methord.

How does ACH's valuation metrics compare to the industry average?

What is the current P/B ratio for Accendra Health Inc (ACH) as of Jan 08 2026?

As of Jan 08 2026, Accendra Health Inc (ACH) has a P/B ratio of -0.42. This indicates that the market values ACH at -0.42 times its book value.

What is the current FCF Yield for Accendra Health Inc (ACH) as of Jan 08 2026?

As of Jan 08 2026, Accendra Health Inc (ACH) has a FCF Yield of -189.39%. This means that for every dollar of Accendra Health Inc’s market capitalization, the company generates -189.39 cents in free cash flow.

What is the current Forward P/E ratio for Accendra Health Inc (ACH) as of Jan 08 2026?

As of Jan 08 2026, Accendra Health Inc (ACH) has a Forward P/E ratio of 2.78. This means the market is willing to pay $2.78 for every dollar of Accendra Health Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Accendra Health Inc (ACH) as of Jan 08 2026?

As of Jan 08 2026, Accendra Health Inc (ACH) has a Forward P/S ratio of 0.07. This means the market is valuing ACH at $0.07 for every dollar of expected revenue over the next 12 months.

ACH Valuation